Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL

Recruiting N/A Interventional Study
Cataract
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
57 (estimated)
Sponsor
Cutting Edge SAS · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation * No ocular comorbidity possibly affecting the study results * Fit within the available IOL diopter range * Have had no previous refractive surgery * Regular …
Contacts

Line Bettinelli, OD

0619530701

line.bettinelli@bausch.com

CONTACT

Christophe Cesses

0786991458

christophe.cesses@bausch.com

CONTACT